Testosterone Gel
Product Images NDC 68180-941

12 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Testosterone (NDC 68180-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 A (B49d821a A323 42d4 912a 7c673e813b36 01)

Figure 1 A (B49d821a A323 42d4 912a 7c673e813b36 01)
An instructional diagram illustrating application areas for Testosterone transdermal gel. It depicts a simplified human torso and upper arms, with shaded regions on the shoulders and upper chest indicating where the gel should be applied.*
FDA Label Image

Figure 1 B (B49d821a A323 42d4 912a 7c673e813b36 02)

Figure 1 B (B49d821a A323 42d4 912a 7c673e813b36 02)
An illustration showing a person with a highlighted area on the upper arm and shoulder, indicating the application site for a transdermal gel.*
FDA Label Image

Structure (B49d821a A323 42d4 912a 7c673e813b36 03)

Structure (B49d821a A323 42d4 912a 7c673e813b36 03)
Chemical structure of Testosterone displayed with molecular formula C19H28O2 and molecular weight 288.42. The diagram shows the steroid backbone and functional groups characteristic of testosterone.*
FDA Label Image

Image 1 (B49d821a A323 42d4 912a 7c673e813b36 04)

Image 1 (B49d821a A323 42d4 912a 7c673e813b36 04)
A line graph depicting total testosterone levels (ng/dL) over a 24-hour period, comparing application sites of Testosterone 16.2 mg/g gel. Data series include 'Upper Arms/Shoulders' and 'Rotation of Abdomen and Upper Arms/Shoulders'. The y-axis shows testosterone concentration, and the x-axis shows time in hours.*
FDA Label Image

Image 2 (B49d821a A323 42d4 912a 7c673e813b36 05)

Image 2 (B49d821a A323 42d4 912a 7c673e813b36 05)
A line graph titled 'Day 112' showing mean total testosterone levels (ng/dl) over time (hours) for Testosterone Gel 1.62% active doses versus placebo. The graph includes error bars (± SD) and indicates normal testosterone range boundaries from 300 to 1000 ng/dl. Testosterone levels remain above placebo and mostly within the normal range across 24 hours.*
FDA Label Image

Image 3 (B49d821a A323 42d4 912a 7c673e813b36 06)

Image 3 (B49d821a A323 42d4 912a 7c673e813b36 06)
A line graph showing mean total testosterone levels (ng/dl) with standard deviation over 24 hours on Day 364 for a group continuing treatment with Testosterone Gel 1.62%. The graph includes upper and lower bounds of the normal testosterone range (300 to 1000 ng/dl) and plots data points at multiple time intervals from 0 to 24 hours.*
FDA Label Image

Image (97ffee98 5264 42cb A650 2f03f3f2a131 174 1)

Image (97ffee98 5264 42cb A650 2f03f3f2a131 174 1)
Testosterone 16.2 mg/g transdermal gel carton for human prescription use, labeled by Lupin Pharmaceuticals, Inc. The packaging is primarily white with black text and includes directional arrow designs.*
FDA Label Image

Figure 1a (B49d821a A323 42d4 912a 7c673e813b36 07)

Figure 1a (B49d821a A323 42d4 912a 7c673e813b36 07)
An anatomical illustration indicating the recommended application sites for testosterone transdermal gel. The shaded areas include the shoulders and upper chest of a male figure, showing where the product should be applied.*
FDA Label Image

Figure 1b (B49d821a A323 42d4 912a 7c673e813b36 08)

Figure 1b (B49d821a A323 42d4 912a 7c673e813b36 08)
An illustration showing the application area for transdermal testosterone gel on the upper arm and shoulder of a male figure. The shaded area indicates where the gel should be applied.*
FDA Label Image

Image (B49d821a A323 42d4 912a 7c673e813b36 222 1)

Image (B49d821a A323 42d4 912a 7c673e813b36 222 1)
The packaging label for Testosterone transdermal gel, 16.2 mg/g strength, presented in a box containing a 30-gram tube. The product is labeled as a human prescription drug by Lupin Pharmaceuticals, Inc. The label displays the proprietary and generic name, dosage form, strength, and quantity.*
FDA Label Image

Container (B49d821a A323 42d4 912a 7c673e813b36 09)

Container (B49d821a A323 42d4 912a 7c673e813b36 09)
Label for Testosterone Gel 1.62% transdermal gel by Lupin Pharmaceuticals, Inc. The label shows dosage details, including 20.25 mg testosterone per pump actuation, with a total content of 88 g. Instructions and warnings indicate the gel's flammability and storage conditions. The label includes a barcode and manufacturing information.*
FDA Label Image

Carton (B49d821a A323 42d4 912a 7c673e813b36 10)

Carton (B49d821a A323 42d4 912a 7c673e813b36 10)
Packaging label for Testosterone Gel 1.62% (16.2 mg/g) gel by Lupin Pharmaceuticals, Inc. Displays dosage form as transdermal gel with active ingredient testosterone. Includes strength per pump actuation and total content of 88 g. The label shows usage warnings, storage instructions, and a barcode. The label highlights that the product is prescription-only (Rx) and manufactured by Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.